SlateStone Wealth’s Celgene Corp CELG Stock Holding History

SlateStone Wealth’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,448	Closed	-$342K	–	229
2019 Q3	$342K	Sell	3,448 -120	-3%	-$11.4K	0.1%	126
2019 Q2	$330K	Sell	3,568 -90	-2%	-$8.55K	0.09%	135
2019 Q1	$345K	Buy	+3,658	New	+$320K	0.11%	120

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

SlateStone Wealth's CELG Position: Q4 2019 in Review

SlateStone Wealth sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,448 shares — an estimated $342K sold.

SlateStone Wealth first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $345K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

SlateStone Wealth reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
SlateStone Wealth sold 3,448 Celgene Corp shares in Q4 2019, an estimated $342K.
SlateStone Wealth first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
SlateStone Wealth's Celgene Corp position peaked at $345K in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SlateStone Wealth's 13F filing for Q4 2019, filed 6 Feb 2020.